Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
206 participants
INTERVENTIONAL
2022-07-04
2023-03-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar
NCT00713999
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
NCT01541631
The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania
NCT03851419
Performance of Tests for Schistosoma Haematobium Diagnosis
NCT06808750
Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya
NCT00463307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
self-collected and operator-collected swab followed by molecular analysis
A single midday urine sample and two cervical-vaginal swabs (both self-collected and speculum-aided collected by a female healthcare worker) will be obtained from participating women and processed using urine filtration and polymerase chain reaction (PCR) for cervico-vaginal samples.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having had prior sexual activity (to allow speculum-aided gynaecological visit and genital sampling),
* resident in any of the selected village of Itilima and Maswa districts,
* irrespective of complaining of urogenital symptoms,
Exclusion Criteria
* Menstruation at the time of visit (since this limits visualization of the cervix and correct sampling);
* no prior sexual activity (since this does not allow the use of a speculum in the visit);
* known pregnancy;
* documented treatment for schistosomiasis in the past 6 months;
* age \<18 or \>45 years;
* unwilling to sign the informed consent form.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Sacro Cuore Don Calabria di Negrar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Sacro Cuore Don Calabria hospital
Negrar, Verona, Italy
Catholic University of Health and Allied Sciences (CUHAS)
Mwanza, , Tanzania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.